Results

Total Results: 1,187 records

Showing results for "weeks".

  1. effectivehealthcare.ahrq.gov/sites/default/files/related_files/ped-mindfulness-protocol-amended.pdf
    September 25, 2024 - • Psychological flexibility (e.g., AFQ-Y, AAQ) • Healthcare utilization Timing • A minimum of 4 weeks … report outcomes at various time points, which we will aggregate into the following intervals: 4 to <8 weeks … , 8 to <12 weeks, 12 weeks to <6 months, 6 months to <12 months, and ≥12 months since the beginning
  2. effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypofractionated-radiation-therapy-draft-appendix-d1.xlsx
    January 01, 2024 - study entry, previous therapy for prostate cancer other than biopsy or transurethral resection, > 12 weeks … preclude obtaining informed consent or adherence to protocol; inability to commence radiotherapy within 26 weeks … NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR No NR No NR NR 8.8 Norkus, 2009 NA NA KQ1 RCT NR (weeks
  3. effectivehealthcare.ahrq.gov/sites/default/files/related_files/omega-3-maternity_disposition-comments.pdf
    October 12, 2016 - consider adding 2 further outcomes in relation to the duration of gestation; early preterm birth <34 weeks … and prolonged gestation >42 weeks. … We did not identify any studies that assessed the risk for late term births (>42 weeks) and only 1 … study appears to have reported the incidence of early preterm births (<34 weeks); we report this outcome … but did for preterm births < 34 weeks gestation (RR 0.99; 95% CI: 0.9, 1.1).
  4. Obesity (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/obesity_hi_impact.pdf
    April 17, 2012 - that the weight loss percentage of 8.0% to 8.9% reported in a study for naltrexone/bupropion at 56 weeks … mimic the effects of GI bypass surgery. 53 The device is intended to remain in place for 12 to 24 weeks … reported that implantation was successful in 26 of 30 patients; however, the device was removed after 12 weeks … The study reported results on 17 obese patients with T2DM who received EndoBarrier for 24 weeks.
  5. Diabetes Mellitus (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1312.pdf
    January 01, 2016 - mg/dL [-38.4 mg/dL to -33.8 mg/dL]), and body weight (-2.5 kg [-2.8 kg to -2.3 kg]) after 24 to 30 weeks … T2DM inadequately controlled with metformin.88 Stage I (n=155) evaluated patient outcomes after 12 weeks … the following results in May 2013:88 HbA1c was significantly lower in all groups after 12 and 24 weeks … Weight was reduced by 2.8-3.7 kg (P < 0.05) at 24 weeks in all except the 20→20 μg/day group. … Benefit occurred for both doses compared with sham at 3 weeks and all subsequent time points.
  6. effectivehealthcare.ahrq.gov/sites/default/files/related_files/ankyloglossia_executive.pdf
    May 01, 2015 - Down syndrome, or craniofacial abnormalities were excluded ,as were studies of premature babies (<37 weeks … ascertainment of the outcomes was not specifically reported, but outcomes were obtained within the first 4 weeks … 6 days of age showed a significant reduction in maternal pain.13 Those performed on infants a few weeks … later frenotomy on nipple pain may relate to cumulative trauma on the breast from several additional weeks
  7. effectivehealthcare.ahrq.gov/sites/default/files/related_files/alcohol-misuse_executive.pdf
    April 28, 2010 - 1 Comparative Effectiveness Review Number 64 Screening, Behavioral Counseling, and Referral in Primary Care To Reduce Alcohol Misuse Executive Summary Background Alcohol misuse, which includes the full spectrum from drinking above recommended limits (i.e., risky/hazardous drinking) to alcohol dependence,1-3 …
  8. effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-stones-draft-appendi-c.xlsx
    January 01, 2024 - 12 weeks NR 164 99 164 NR NR NR 62 60 (46, 67) 15 (24.2) NR 47 61 (46, 67) 11 (23.4) NR 55 56 (41, 64 … 8 weeks None; continued use of existing KSD prevention medications was permitted as long as there were … no dose changes planned or within the 8 weeks prior to study entry N (%) using calcium for KSD risk … None 4 weeks per protocol Adherence to the study drug based on pill counts exceeded 96% Results were … reported but are not eligible because they were only reported at 8 weeks NR NR Results were reported
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/alcohol-misuse-drug-therapy-surveillance.pdf
    September 01, 2017 - Craving; cue reactivity Timing/ Length of follow-up At least 12 weeks of follow up from the time … Less than 12 weeks Settings Outpatient health care (i.e., non-laboratory) settings, including studies … We would appreciate hearing back from you in the next two weeks (by August 11, 2017). … Of concern, anxiety increased over time in baclofen patients, from 5% during titration (weeks 1-7) … to 16% during taper-off (weeks 24-26.)43 An RCT of baclofen in veterans with Hepatitis C (n=180) reported
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/binge-eating_executive.pdf
    December 01, 2015 - The draft report was posted on the AHRQ Web site for 4 weeks to elicit public comment. … Given the limited impact on weight and the short length of treatment (6 to 12 weeks), finding no difference … short studies (e.g., outcomes measured only at end of treatment, which could be just a matter of weeks
  11. effectivehealthcare.ahrq.gov/health-topics/sinusitis
  12. effectivehealthcare.ahrq.gov/health-topics/postpartum-care
  13. effectivehealthcare.ahrq.gov/sites/default/files/related_files/partial-breast-irradiation-disposition-comments.pdf
    January 31, 2023 - Conventionally fractionated WBI has largely been supplanted by hypofractionation completed over approximately 3 weeks … compared with a hypofractionated WBRT control that is gentler on the normal tissues - 40Gy in 15F over 3 weeks … This is compared to “traditional” dose/fractionated RT over ~6 weeks, a point which needs to be highlighted
  14. S3 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/s3.pdf
    October 01, 2007 - Against this backdrop, Harry stood out on that first morning and throughout the following 6 weeks of
  15. effectivehealthcare.ahrq.gov/sites/default/files/Evidence%20Summary_1.pdf
    April 01, 2020 - This review required studies of cognition and function to be at least 24 weeks long, and studies of … agitation, aggression, and psychosis to be at least 2 weeks long; trials reporting only on acute and … In addition, few included trials were longer than 26 weeks, so longer-term drug effects were unclear … analyses due to high risk of bias, often because of high attrition, especially trials longer than 26 weeks … treatment efficacy and harms of prescription drugs in patients with CATD and BPSD and were at least 2 weeks
  16. #14 SUBSTANCE ABUSE (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/14_substance_abuse_potential_high_impact_2012-12-11.pdf
    January 01, 2012 - participants who were smokers, the study authors reported that 14.3% of the participants quit smoking at 4 weeks … arm. 5 The trial is expected to enroll 500 participants and to gather followup cessation data at 6 weeks … problems of low adherence and medication diversion because the drugs’ effects may last for several weeks
  17. effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs4-active-infection-rapid-response.pdf
    May 01, 2024 - with carbapenem, 3rd- or 4th- generation cephalosporin, or fluoroquinolone for >3 days during 2 weeks
  18. effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/epc-maternal-health-grand-rounds-slides.pptx
    January 01, 2023 - healthcare is provided Dedicated PP visit, part of well-child visit 3 When healthcare is provided 2 weeks … , 6 weeks 4 Who provides healthcare/support Predominantly health system-based care Predominantly community-based
  19. effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-brain-injury_executive.pdf
    April 01, 2011 - double-blind placebo controlled trial with block randomization, in which treatment was administered for 10 weeks … in 54 patients; however, low response rates resulted in a study extension for 26 participants to 10 weeks … Among participants with data at 10 weeks, 46.2 percent were responders and 26.9 were in remission.
  20. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-270-bimp-executive-summary.pdf
    May 01, 2024 - In adults with chronic migraine, behavioral sleep modification may reduce headache frequency at 6 weeks

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: